Business
Sensex Gains 2,072 Points, Nifty Above 25,700; US-India Trade Deal Among Key Factors Behind Rally
Last Updated:
Indian benchmark indices staged a powerful rally, with the Nifty and Sensex surging up to 4.7% and 4.4% respectively; Know key reasons
Nifty50
Indian benchmark indices staged a powerful rally, with the Nifty and Sensex surging up to 4.7% and 4.4%, respectively, marking one of their strongest single-day advances. The sharp upswing followed the announcement of a long-awaited India–US trade agreement, which helped ease tariff-related worries that had weighed on domestic equities for months.
The benchmark BSE Sensex ended 2072.67 points higher or 2.54% to end at 83,739.13. The Nifty 50 climbed 639.15 points, or 2.55%, to end at 25,727.55 during the session.
Earlier in the day, the BSE Sensex jumped 5.1% during the session to hit an intraday peak of 85,871.73. Meanwhile, the Nifty 50 advanced by 1,252 points, or 5%, climbing to 26,341.2 as buying intensified across the board.
The sharp move also led to a massive rise in investor wealth. The combined market capitalisation of BSE-listed companies increased to Rs 467.35 lakh crore from ₹455 lakh crore in the previous session, translating into a gain of more than Rs 12.5 lakh crore in a single day as participation broadened across sectors.
Highlighting the reasons that are fueling the Indian stock market today, Santosh Meena, Head of Research at Swastika Investmart, said, “The Indian stock market today is in a bull trend due to the announcement of the India-US trade deal. The much-awaited trade deal has the potential to significantly improve sentiment across markets and among FIIs. After a strong gap-up opening during the Opening Bell, the possibility of the Nifty 50 index hitting fresh all-time highs in the near term cannot be ruled out. The Indian rupee is also expected to strengthen meaningfully.”
On segments that may benefit in upcoming sessions after the India-US trade deal, Santosh Meena of Swastika Investmart, said, “Export-oriented sectors are likely to be the key beneficiaries—textiles and apparel, gems & jewellery, leather, marine/seafood (shrimp), auto ancillaries, engineering goods, speciality chemicals, and select electronics and consumer goods. Pharma and IT/services may also witness an indirect sentiment boost.”
What’s driving the rally
India–US trade deal
After prolonged negotiations, India and the US sealed a trade agreement under which Washington cut reciprocal tariffs on Indian goods to 18% from 50%. In return, India will reduce tariffs and non-tariff barriers on American products. The breakthrough removes a major uncertainty that had kept foreign investors cautious and contributed to Indian equities’ underperformance. Through January, the Nifty had slumped over 1,000 points at its worst, even as foreign portfolio investors sold heavily.
Rupee strength adds comfort
A stronger rupee also supported sentiment, easing some pressure from global volatility. The currency opened at 90.40 against the dollar versus its previous close. Analysts believe the combined effect of the India–US deal, progress on the EU trade front and a growth-focused Budget could lift sentiment and revive risk appetite across markets.
FII short covering
Short covering by foreign institutional investors amplified the rebound. With bearish positions estimated to be close to 90%, traders rushed to unwind shorts as indices rebounded from oversold levels and the Nifty reclaimed the 26,000 mark. Anand James, Chief Market Strategist at Geojit Investments, said a sustained move above 25,000 opens the door to 25,800 and possibly 26,200, though failure to hold above 25,800 could trigger consolidation toward the 25,430–25,340 zone.
Heavyweights power gains
Large-cap stocks led from the front. Reliance Industries climbed nearly 4%, while Adani Ports surged about 8%, giving strong momentum to the benchmarks. HDFC Bank, L&T, Bajaj Finance, ICICI Bank, Infosys and Eternal gained up to 5%. Optimism around the Union Budget 2026’s capital expenditure push further strengthened expectations of better order flows.
Buzz for strong quarterly numbers
On how the India-US trade deal may benefit the Indian stock market in the medium to long term, Seema Srivastava, Senior Research Analyst at SMC Global Securities, said, “The India-US deal is expected to benefit export-oriented companies, especially the auto, IT, textile, pharma, gems and jewellery. So, companies from these segments are expected to report strong quarterly numbers in the upcoming quarters.” She said that the market would try to discount that buzz much before the companies start reporting such robust quarterly numbers.
Supportive global cues
Global markets also offered tailwinds. The Dow Jones rose roughly 515 points (1.05%), the S&P 500 gained 0.5%, and the Nasdaq advanced about 0.6%. Asian equities rallied, with Japan’s Nikkei jumping around 3% and South Korea’s Kospi soaring over 5%. Hong Kong’s Hang Seng and China’s CSI 300 posted modest gains, while Australia’s S&P/ASX 200 climbed 1.3% after the Reserve Bank of Australia raised its policy rate by 25 basis points to 3.85%, its first hike since November 2023.
Stocks to buy after India-US trade deal
On stocks to buy in the wake of the India-US trade deal and the reduction of Trump’s tariffs on India, Anuj Gupta, a SEBI-registered market expert, recommended 21 stocks to buy today from the auto, IT, pharma, textile, and defence sectors.
Pharma: Aurobindo Pharma, Cipla, and Glenmark Pharmaceuticals.
Defence: BEL, HAL, and Cochin Shipyard.
IT: TechM, HCL Tech, Wipro, and Infosys.
Textile: Trident and Welspun Living.
Auto and Auto Ancillary: Eicher Motors, Tata Motors, TVS Motor, Bajaj Auto, JBM Auto, Bosch, Amara Raja, and Exide Industries.
February 03, 2026, 11:30 IST
Read More
Business
Vets to be legally required to publish price lists and cap prescription fees
Vets will be legally bound to prescription fee caps and publishing price lists among new measures which will start coming into force later this year, the competition watchdog has announced.
The Competition and Markets Authority (CMA) said its final reforms for the sector will help pet owners better navigate the vet services market.
Other legally binding measures will include a price comparison website and mandatory branding by the large groups to boost competition and drive down prices.
The CMA said pet owners using a vet practice that is part of a larger chain can expect to see changes before Christmas, including standard price lists.
The measures follow the CMA finding that fees have risen at almost twice the rate of inflation, with pet owners not being given enough information about their vet and the prices of treatments.
Martin Coleman, chairman of the independent Inquiry Group, said: “This is the most extensive review of veterinary services in a generation, and today’s reforms will make a real difference to the millions of pet owners who want the best for their pets but struggle to find the practice, treatment and price that meets their needs.
“Too often, people are left in the dark about who owns their practice, treatment options and prices – even when facing bills running into thousands of pounds.
“Our measures mean it will be made clear to pet owners which practices are part of large groups, which are charging higher prices, and for the first time, vet businesses will be held to account by an independent regulator.
“Our changes put pet owners at the centre but also help vets by enhancing trust in the profession and protecting clinical judgment from undue commercial pressure – and that is important to ensure our pets continue to get the best care.”
The CMA said practices must publish a comprehensive price list for standard services, including consultations, common procedures, diagnostics, written prescriptions and cremation options under its new rules.
Prescriptions – for which “many” practices charge £30 or more for each – are to be capped at £21 for the first medicine and £12.50 for any additional medicines.
Practices must also provide a written estimate in advance for any treatment expected to cost £500 or more, including aftercare costs, as well as an itemised bill.
Emergency care will be the only exception for written estimates.
Prices and information about who owns the surgery are to be made available to pet owners through the Royal College of Veterinary Surgeons (RCVS) ‘Find a Vet’ service, which will share the data with third-party comparison sites.
Vet businesses must make it clear whether they are part of a group or an independent business, with details of group ownership to be displayed on signs at the surgery and online.
British Veterinary Association president Rob Williams said: “The majority of the CMA’s measures focus on increasing transparency and information, which will help pet owners make more informed choices and support competition, which is a really positive step.”
He added: “Delivering highly skilled veterinary medicine is costly and whilst we recognise prices have risen sharply in recent years this is due to a number of factors, including the higher costs all businesses are experiencing – and vet practices are not immune.
“Plus, thanks to advances in diagnostics and medical technology over the last 20 years, vets can now do much more to manage disease and injury in animals, whereas in the past the only option available may have been to euthanase.
“Owners today also have a greater expectation of their vet, with many expecting human quality healthcare for their pets and whilst this is possible to deliver, it comes at a cost.”
Business
Gold price prediction today: Pressure on gold prices to continue on March 24, 2026 amid US-Iran war? Check outlook – The Times of India
Gold price prediction today: Gold prices are likely to remain range-bound in the near future, says Praveen Singh, Head Currencies and Commodities, Mirae Asset ShareKhan
Source link
Business
Estée Lauder is in talks to merge with Puig amid ongoing turnaround plan
An Estée Lauder pop-up store is seen inside a Daimaru store on Nanjing Road in Shanghai, China, Aug. 6, 2021.
Costfoto | Future Publishing | Getty Images
Estée Lauder Companies said Monday that it is in talks with Spanish beauty group Puig to potentially merge the two companies.
“No final decision has been made, and no agreement has been reached,” Estée Lauder said in a statement.
Shares of the U.S. beauty company were down nearly 8% following the news, which was first reported by the Financial Times. Puig’s stock rose roughly 3%.
Puig owns major beauty brands including Charlotte Tilbury, Jean Paul Gaultier and Rabanne. The companies did not disclose any financial details of the potential deal.
Estée Lauder has been struggling amid ongoing headwinds from tariffs and its restructuring as it enacts its “Beauty Reimagined” turnaround plan to revitalize the business. In its second-quarter earnings report last month, the beauty retailer said it’s expecting a $100 million hit to its full-year profitability due to tariff impacts.
Estée Lauder’s stock has dropped roughly 25% this year.
-
Sports1 week agoJapan suffers shocking collapse to Venezuela in World Baseball Classic
-
Entertainment1 week agoStrategic oil stocks to be released ‘immediately’ in Asia and Oceania: IEA
-
Business1 week agoNew Income Tax Act 2025 To Take Effect From April 1: 10 Key Changes That Will Affect Your Money
-
Sports1 week agoTransfer rumors, news: Real Madrid open to Camavinga exit, as Premier League clubs circle
-
Tech6 days agoJustice Department Says Anthropic Can’t Be Trusted With Warfighting Systems
-
Sports6 days agoMarch Madness 2026 – How to watch in SA, start time, schedule, TV channel for NCAA championship basketball tournament
-
Sports1 week agoPCB files complaint over allowing Bangladesh to take review on penultimate ball – SUCH TV
-
Business7 days agoStocks and pound rise as US rate call approaches
